ICIs Linked With Higher Risk for Cancer Therapy-Related Cardiac Dysfunction
In a study presented at AHA 2021, researchers aimed to assess the link between cancer therapy-related cardiac dysfunction and immune checkpoint inhibitors.
In a study presented at AHA 2021, researchers aimed to assess the link between cancer therapy-related cardiac dysfunction and immune checkpoint inhibitors.
Patients with heart failure of mostly ischemic etiology were found to have increased burden of mendelian cardiomyopathy variants compared with control individuals.